BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6579008)

  • 1. Ochratoxin A.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():191-206. PubMed ID: 6579008
    [No Abstract]   [Full Text] [Related]  

  • 2. Furazolidone.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():141-51. PubMed ID: 6579002
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-amino-5-nitrothiazole.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():71-7. PubMed ID: 6579018
    [No Abstract]   [Full Text] [Related]  

  • 4. Gyromitrin (acetaldehyde formylmethylhydrazone).
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():163-70. PubMed ID: 6579004
    [No Abstract]   [Full Text] [Related]  

  • 5. Quercetin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():213-29. PubMed ID: 6579010
    [No Abstract]   [Full Text] [Related]  

  • 6. Kaempferol.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():171-8. PubMed ID: 6579005
    [No Abstract]   [Full Text] [Related]  

  • 7. Petasitenine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():207-12. PubMed ID: 6579009
    [No Abstract]   [Full Text] [Related]  

  • 8. Metaldehyde toxicity: a review.
    Booze TF; Oehme FW
    Vet Hum Toxicol; 1985 Feb; 27(1):11-9. PubMed ID: 3883640
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of action of ochratoxin A, probable agent of endemic Balkan nephropathy].
    Dirheimer G; Röschenthaler R; Creppy E
    Bull Acad Natl Med; 1983 Jan; 167(1):67-74. PubMed ID: 6196096
    [No Abstract]   [Full Text] [Related]  

  • 10. Carrageenan.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():79-94. PubMed ID: 6579019
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotransformation and nephrotoxicity of ochratoxin B in rats.
    Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W
    Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of ochratoxin A: an update.
    Kuiper-Goodman T
    Food Addit Contam; 1996; 13 Suppl():53-7. PubMed ID: 8972354
    [No Abstract]   [Full Text] [Related]  

  • 13. Progesterone.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Dec; 21():491-515. PubMed ID: 120841
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicological studies on zimeldine.
    Malmfors T
    Acta Pharm Suec; 1983; 20(4):295-310. PubMed ID: 6227204
    [No Abstract]   [Full Text] [Related]  

  • 15. Ochratoxin A.
    IARC Monogr Eval Carcinog Risk Chem Man; 1976; 10():191-7. PubMed ID: 791799
    [No Abstract]   [Full Text] [Related]  

  • 16. Is ochratoxin a nephrotoxic in human beings?
    Godin M; Fillastre JP; Simon P; Francois A; Roy FL; Morin JP
    Adv Nephrol Necker Hosp; 1997; 26():181-206. PubMed ID: 8922134
    [No Abstract]   [Full Text] [Related]  

  • 17. Mineral oils (lubricant base oils and derived products).
    IARC Monogr Eval Carcinog Risk Chem Hum; 1984 Apr; 33():87-168. PubMed ID: 6590457
    [No Abstract]   [Full Text] [Related]  

  • 18. Cinnamyl anthranilate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():133-9. PubMed ID: 6579001
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-azacytidine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():37-46. PubMed ID: 6168559
    [No Abstract]   [Full Text] [Related]  

  • 20. Senkirkine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():231-8. PubMed ID: 6579011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.